Healthcare - Medical - Care Facilities - NASDAQ - US
$ 0.0361
-4.75 %
$ 688 K
Market Cap
-0.03
P/E
CASH FLOW STATEMENT
-2.24 M
OPERATING CASH FLOW
-49.2 K
INVESTING CASH FLOW
764 K
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Novo Integrated Sciences, Inc.
| Net Income | -13.3 M |
| Depreciation & Amortization | 2.3 M |
| Capital Expenditures | -49.2 K |
| Stock-Based Compensation | 385 K |
| Change in Working Capital | 461 K |
| Others | 7.42 M |
| Free Cash Flow | -2.29 M |
Cash Flow
Millions
| Aug-2023 | Aug-2022 | Aug-2021 | Aug-2020 | Aug-2019 | Aug-2018 | Aug-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||||||||||
| Net Income | (13.3) | (33.0) | (4.5) | (4.9) | (0.4) | (2.1) | (0.7) | (0.2) | (2.8) | (1.0) | (0.9) | (1.2) | (2.2) | (2.6) | (2.3) | (1.0) | (2.5) | (1.5) | (1.1) | (0.3) |
| Depreciation & Amortization | 2.3 | 3.0 | 1.7 | 1.4 | 97.1 K | 73.4 K | 67.8 K | 72.6 K | 1.01 K | 5.7 K | 4.83 K | 4.52 K | 3.84 K | 4.84 K | 6.55 K | 18.1 K | 12 K | 2.3 K | 909 | 25.2 K |
| Deferred Income Tax | 0 | 16.4 | 77.5 K | 0.4 | (0.1) | 0 | 0 | 0 | 82.8 K | 0 | 0 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 0.4 | 0.4 | 0.2 | 2.3 | 70.8 K | 1.3 | 0.3 | 50.3 K | 0.3 | 0 | 0 | 21.6 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Operating Activities | 7.9 | 8.2 | 1.5 | 1.2 | 0.2 | 2.0 | 1.5 | 50.3 K | 2.3 | 0.7 | 0.4 | 0.7 | 1.1 | 0.8 | 1.2 | 0.3 | 1.4 | 0.6 | 0.7 | 98.6 K |
| Change in Working Capital | 0.5 | (0.8) | 29.1 K | (0.9) | (0.7) | (0.2) | (0.4) | 4.81 K | 11.4 K | 0.2 | 0.2 | 0.2 | 0.7 | 0.2 | 0.1 | 0.4 | 0.6 | 0.4 | 0.3 | 82.4 K |
| Cash From Operations | (2.2) | (5.9) | (1.0) | (0.4) | (0.8) | (0.9) | (0.8) | (0.1) | (0.2) | (0.1) | (0.2) | (0.4) | (0.5) | (1.6) | (1.0) | (0.3) | (0.5) | (0.5) | (0.1) | 75.8 K |
| INVESTING CASH FLOW | ||||||||||||||||||||
| Capital Expenditures | 49.2 K | (0.2) | (0.3) | 12.1 K | (0.1) | (0.2) | 38.2 K | 55 K | (0.1) | 1 K | 0 | 15 K | 3.61 K | (0.1) | 1.75 K | 0 | 35.4 K | 3.09 K | 0 | 0 |
| Other Items | 0 | 0.4 | 3.3 | 0.7 | (0.7) | 38.6 K | (0.7) | (0.4) | 0 | 0 | 0 | (0.2) | 0 | 2.5 K | 0 | 0 | 0 | 0 | 0 | 19.1 K |
| Cash From Investing Activities | 49.2 K | 0.2 | 3.0 | 0.7 | (0.8) | (0.2) | (0.7) | (0.5) | (0.1) | 1 K | 0 | (0.2) | 3.61 K | (0.1) | 1.75 K | 0 | 35.4 K | 3.09 K | 0 | 19.1 K |
| FINANCING CASH FLOW | ||||||||||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (1.6) | (0.4) | (2.8) | (0.2) | 0 | 7 K | (0.1) | 0 | 17.9 K | 71.6 K | 0.1 | 0.2 | 92.5 K | 0.2 | 0.4 | 95 K | 0 | 0 | 23.6 K | 62.2 K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.5 | 0 | (0.2) | (0.2) | (0.2) | 20.1 K | (0.1) | 0 | 0 | 0 | 0 | 3.57 K | 5 K | 0 | 43.6 K | 15.1 K | 48.1 K | 0.1 | 0 | 73.1 K |
| Cash From Financing Activities | 0.8 | (0.4) | 4.3 | (0.3) | 3.1 | 11.6 K | 3.1 | 0.1 | 0.2 | 0.1 | 0.2 | 0.6 | 0.3 | 1.2 | 1.6 | 0.3 | 0.5 | 0.4 | 0.1 | 54.2 K |
| CHANGE IN CASH | ||||||||||||||||||||
| Net Change In Cash | (1.8) | (6.1) | 6.2 | 15.9 K | 1.4 | (1.2) | 1.8 | 40.2 K | 12.3 K | 1.59 K | 2.87 K | 5.34 K | (0.1) | (0.5) | 0.6 | 35 | 1.74 K | 12.4 K | 13.5 K | 2.49 K |
| FREE CASH FLOW | ||||||||||||||||||||
| Free Cash Flow | (2.3) | (6.1) | (1.3) | (0.5) | (0.9) | (1.1) | (0.8) | (0.2) | (0.3) | (0.1) | (0.2) | (0.4) | (0.5) | (1.7) | (1.0) | (0.3) | (0.5) | (0.5) | (0.1) | 75.8 K |